> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Indica Labs Digital Pathology Platform Cleared
- URL: https://www.fdaweb.com/indica-labs-digital-pathology-platform-cleared/
- Published: 2024-05-14T12:00:00.000Z
- Updated: 2026-09-14T14:30:50.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5156972

FDA has cleared an Indica Labs 510(k) for [HALO AP Dx](https://indicalab.com/clinical-products/halo-ap-dx/?ref=fdaweb.com), a digital pathology platform that Indica says enables slides to be reviewed from any location the moment they are scanned, allowing pathologists to diagnose cases remotely without waiting on the physical transfer of slides. The clearance allows HALO AP Dx to be “utilized in conjunction with the Hamamatsu NanoZoomer S360MD Slide scanner for *in-vitro* diagnostic use and sets the stage for use with additional FDA-cleared slide scanners in the future,” the company says. The platform is interoperable, “creating a custom-built environment for digital pathology and for a variety of pathologic specialties, even those with unique technical requirements,” it adds. Additionally, HALO AP Dx can be deployed in either a cloud-based or on-premises environment.